Dermatol Clin. 2003 Jul;21(3):469-79, vi.

The use of oral antifungal agents to treat onychomycosis.

Source

Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook Site), University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada. agupta@execulink.com

Abstract

Onychomycosis has been treated for years with oral antifungal agents, and more recently in the United States with a topical nail lacquer. Griseofulvin was the first significant oral agent available to manage onychomycosis. The introduction of the azoles (ketoconazole, itraconazole, and fluconazole) and the allylamine, terbinafine, led to improved cure rates and a broad spectrum of activity. Pharmacokinetic studies have shown that the newer oral agents penetrate the nail within approximately one to two weeks after the start of therapy and remain for several months after the end of treatment. This article reviews the oral antifungal agents used to treat onychomycosis.

PMID:: 12956199; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

LinkOut - more resources

Full Text Sources

MD Consult

Other Literature Sources

Medical

Skin Infections - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. [J Am Acad Dermatol. 2000]
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK. J Am Acad Dermatol. 2000 Oct; 43(4 Suppl):S81-95.
Review The systemic treatment of onychomycosis. [Clin Podiatr Med Surg. 1995]
Review The systemic treatment of onychomycosis.
Wenig JA. Clin Podiatr Med Surg. 1995 Apr; 12(2):263-74.
Review The new oral antifungal agents for onychomycosis of the toenails. [J Eur Acad Dermatol Venereol. ...]
Review The new oral antifungal agents for onychomycosis of the toenails.
Gupta AK, Shear NH. J Eur Acad Dermatol Venereol. 1999 Jul; 13(1):1-13.
Review Oral therapeutic agents in fungal nail disease. [J Am Acad Dermatol. 1994]
Review Oral therapeutic agents in fungal nail disease.
Roberts DT. J Am Acad Dermatol. 1994 Sep; 31(3 Pt 2):S78-81.
Review Toenail onychomycosis: current and future treatment options. [Dermatol Ther. 2007]
Review Toenail onychomycosis: current and future treatment options.
Finch JJ, Warshaw EM. Dermatol Ther. 2007 Jan-Feb; 20(1):31-46.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The use of oral antifungal agents to treat onychomycosis.
The use of oral antifungal agents to treat onychomycosis.
Dermatol Clin. 2003 Jul ;21(3):469-79, vi.

PubMed
Eye diseases in general out-patient clinic in Ibadan.
Eye diseases in general out-patient clinic in Ibadan.
Niger J Med. 2003 Apr-Jun ;12(2):76-80.

PubMed
Disease and health seeking patterns among adolescents in Uganda.
Disease and health seeking patterns among adolescents in Uganda.
Int J Adolesc Med Health. 2003 Apr-Jun ;15(2):105-12.

PubMed
RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast...
RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
Hum Mutat. 2003 Oct ;22(4):337.

PubMed
Fifty years' experience of reduced-tar cigarettes: what do we know about their h...
Fifty years' experience of reduced-tar cigarettes: what do we know about their health effects?
Inhal Toxicol. 2003 Sep 15 ;15(11):1059-102.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The use of oral antifungal agents to treat onychomycosis.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information